Clinical trial

Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy

NCT03262363

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-08-01

PhasePHASE2 / PHASE3

Study timeline

Study start (estimated)2018-08-01Date precision: day

Registry last updated2018-05-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Kidney Diseasesunresolved

Diabetes Mellitus, Type 2unresolved

Polymorphismunresolved

Interventions

Curcumin/NFE2L2 A>GCOMBINATION_PRODUCT

Placebo/NFE2L2 A>GCOMBINATION_PRODUCT

Sponsors & collaborators

Unidad de Investigacion Medica en Enfermedades Renaleslead sponsor

Mapped research locations

GuadalajaraJalisco, Mexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03262363 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.